Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Inovio Pharmaceuticals is a biotech company developing DNA medicines and delivery devices to treat infectious diseases, cancers, and HPV-related conditions. Its platform uses proprietary plasmids and electroporation technology to induce targeted immune responses. Core products include immunotherapies for HPV, glioblastoma, Ebola, and COVID-19, with a focus on in vivo protein production, immune activation, and rapid, scalable manufacturing.
This description was generated via AI from an annual report. Updated about 1 year ago.